Abstract
Cardiac sympathetic denervation (CSD) is a useful therapeutic option for patients with ventricular arrhythmias (VAs) refractory to anti-arrhythmic agents and/or catheter ablation. However, the experience is mostly limited to non-structural heart disease in paediatric patients. The advent of video-assisted thoracoscopic surgery (VATS) with its reduced morbidity has encouraged the use of VATS CSD in patients with structural heart disease. In this series, we report the surgical and cardiac outcomes of VATS–guided CSD in four patients who presented with electrical storm in the setting of different structural cardiomyopathies. Four patients underwent VATS–guided CSD at our centre during the period 2019–2021 after failure of conventional medical and/or ablative treatment for the management of refractory VAs. All four patients presented with electrical storm with different cardiomyopathies including ischaemic (post-acute myocardial infarction) and non-ischaemic aetiologies (sarcoidosis, non-specific right ventricular cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy). A combined total of 349 implantable cardioverter defibrillator (ICD) shocks were registered in the 4 weeks preceding the procedure with mean shocks of 87 per patient. All four patients successfully underwent CSD through the VATS approach with no operative mortality or any major surgical morbidity. All patients had resolution of electrical storms with 75% of patients remaining free of ICD shocks at a mean follow-up of 14.87 months. One patient who remained free of ICD shocks and recurrent VAs died at 23 months after the procedure due to progressive heart failure and complications. VATS CSD is a safe and effective complementary therapeutic modality in patients with life-threatening refractory VAs and electrical storms irrespective of the underlying substrate.
Similar content being viewed by others
References
Chihara RK, Chan EY, Meisenbach LM, Kim MP. Surgical cardiac sympathetic denervation for ventricular arrhythmias: a systematic review. Methodist DeBakey Cardiovasc J. 2021;17:24–35. https://doi.org/10.14797/QIQG9041.
Nguyen HL, Vaseghi M. Sympathetic denervation for treatment of ventricular arrhythmias. J Atr Fibrillation. 2020;13:2404. https://doi.org/10.4022/jafib.2404.
Hofferberth SC, Cecchin F, Loberman D, Fynn-Thompson F. Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. J Thorac Cardiovasc Surg. 2014;147:404–9. https://doi.org/10.1016/j.jtcvs.2013.07.064.
Weatherford DA, Stephenson JE, Taylor SM, Blackhurst D. Thoracoscopy versus thoracotomy: indications and advantages. Am Surg. 1995;61:83–6.
Vaseghi M, Gima J, Kanaan C, et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm. 2014;11:360–6. https://doi.org/10.1016/j.hrthm.2013.11.028.
Wu P, Vaseghi M. The autonomic nervous system and ventricular arrhythmias in myocardial infarction and heart failure. Pacing Clin Electrophysiol. 2020;43:172–80. https://doi.org/10.1111/pace.13856.
Sinkar K, Bagchi A, Mahajan A, et al. Acute hemodynamics of cardiac sympathetic denervation. Indian Pacing Electrophysiol J. 2020;20:237–42. https://doi.org/10.1016/j.ipej.2020.06.006.
Prabhu MA, Prasad SBV, Abhilash SP, Thajudeen A, Balasubramoniam KR, Namboodiri N. Left sympathetic cardiac denervation in managing electrical storm: acute outcome and long term follow up. J Interv Card Electrophysiol. 2016;47:285–92. https://doi.org/10.1007/s10840-016-0153-2
Ajijola OA, Vaseghi M, Mahajan A, Shivkumar K. Bilateral cardiac sympathetic denervation: why, who and when? Expert Rev Cardiovasc Ther. 2012;10:947–9. https://doi.org/10.1586/erc.12.93.
Vaseghi M, Shivkumar K. The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis. 2008;50:404–19. https://doi.org/10.1016/j.pcad.2008.01.003.
Vaseghi M, Barwad P, Malavassi Corrales FJ, et al. Cardiac sympathetic denervation for refractory ventricular arrhythmias. J Am Coll Cardiol. 2017;69:3070–80. https://doi.org/10.1016/j.jacc.2017.04.035.
Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol. 1976;37:1034–40. https://doi.org/10.1016/0002-9149(76)90420-3.
Funding
Not applicable.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics committee approval
Ethical clearance was obtained from the institutional ethics committee, and the reference number for the same is IEC/353/6/2021.
Informed consent
Informed consent was taken from all the patients both for surgery as well as for utilization of their information for medical, scientific and educational purposes, provided their identity is not revealed by any picture or text accompanying them.
Conflict of interest
The authors have no conflicts of interest.
Statements of human and animal rights
The authors declare that no experiments were performed on humans or animals for this study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(MP4 91,123 kb)
Rights and permissions
About this article
Cite this article
Mittal, S., Deepti, S., Abraham, J. et al. VATS cardiac sympathetic denervation for ventricular arrhythmias: initial experience in a tertiary care centre. Indian J Thorac Cardiovasc Surg 38, 515–520 (2022). https://doi.org/10.1007/s12055-022-01361-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12055-022-01361-y